The EPA and DHA market includes products derived from marine sources containing omega-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). EPA and DHA play an important role in brain and eye development in infants as well as protecting cardiovascular health in adults. They help reduce inflammation and lower risks of stroke, coronary heart disease, depression, and cognitive decline. Increasing awareness about health benefits of EPA and DHA has boosted demand for functional foods and beverages fortified with these fatty acids. The global EPA and DHA market is estimated to be valued at US$ 2135.1 Mn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the EPA and DHA market are KHS GmbH, Tetra Pak International SA (Tetra Laval Group), Syntegon Technology GmbH, JBT Corporation, GEA Group Aktiengesellschaft, Sidel Group (Tetra Laval Group), Krones AG, Ronchi Mario SPA, Coesia Group, and Barry-Wehmiller Companies Inc. These players are focusing on new product launches and innovations to meet the rising demand.

The growing demand for Global EPA And DHA Market Size supplements can be attributed to increasing health consciousness among consumers and shifting preference towards preventive healthcare. The increasing cases of lifestyle diseases and cardiometabolic disorders are prompting people to include EPA and DHA in their diets for obtaining associated health benefits.

Technological advancements are helping players improve the production and purification processes of EPA and DHA. Companies are investing in R&D to develop new techniques to extract these fatty acids from algae on a commercial scale and with higher yields. Algal DHA and EPA are likely to gain traction and meet the rising demand.

Market Trends

High oxidative stability of EPA and DHA makes them suitable for usage in various food processing techniques involving heat and other treatments. This is driving innovations in snacks and bakery products fortified with EPA and DHA. Furthermore, miniaturization of encapsulation technology is allowing manufacturers to offer EPA and DHA in smaller capsule sizes.

The growing vegan population is prompting companies to develop plant-based sources of EPA and DHA. Companies are exploring new sources of omega-3 such as certain microalgae to obtain EPA and DHA without involving marine sources. This is expected to provide new opportunities over the forecast period.

Market Opportunities

Innovations in microencapsulation techniques are enabling stable delivery of EPA and DHA in various delivery forms. This will support development of EPA and DHA fortified products across diverse categories like infant formula, dairy, confectionery etc.

Rising investments towards algal DHA and EPA commercialization present significant growth prospects. Low-cost commercial production of algal EPA and DHA at scale can help meet the massive global demand.

Impact of COVID-19 on EPA and DHA Market

The COVID-19 pandemic has severely impacted the growth of the EPA and DHA market on a global level. During the initial lockdown phases imposed by various governments worldwide, supply chain disruptions were witnessed as production and transportation came to a standstill. This led to shortage of raw materials and finished products. Moreover, with restrictions on non-essential travel and social distancing measures in place, demand from Food and Beverage and Dietary Supplement industries saw a decline initially.

However, as people became more health conscious during the pandemic, demand for products containing omega-3 fatty acids like EPA and DHA increased among consumers. This was due to growing awareness about importance of these nutrients in building immunity and overall wellness. Manufacturers started diversifying their product portfolio to cater to rising demand for high-nutrition and immunity booster products. Several new product launches in functional food and beverage categories have been witnessed since mid-2020.

With mass vaccination drives underway globally, economic and business activities are recovering gradually. While supply chain issues persist, companies are adapting new strategies like minimizing warehouse stockouts and establishing local sourcing partnerships. The long-term outlook remains positivedriven by sustained demand for nutrition-rich and healthy foods. However, future waves of the pandemic or emergence of new variants poses challenges. Continued R&D in production technologies and new ingredients will be crucial for achieving stability and growth in the coming years.

Europe holds the largest share in EPA and DHA market in terms of value currently, due to strong demand from Food industries and increasing adoption of supplements. Countries like Germany, France and UK are major revenue generators. Asia Pacific is the fastest growing regional market driven by rising health consciousness, growing middle class and expansion of end-use industries in developing economies like India and China. Manufacturers are focusing on these emerging countries for business expansion through collaborations and capacity additions.

Get More Insights On This Topic: https://www.pressreleasebulletin.com/epa-and-dha-market-forecast-outlook-trend-2023-2030/